论文部分内容阅读
Tamoxifenresistance leads to lethality in a substantial fraction of estrogen positivebreast cancer patients.Here,we show that high p21-activated kinase-4(PAK4)expression was linked to poor patient outcome in tamoxifen-treated breast cancer patients.